A new licence to clone.
Many countries are still grappling with the issue of therapeutic cloning of human cells as the UN tackles this issue alongside reproductive cloning, but in the UK a new programme looking at the causes of motor neuron disease has recently been sanctioned. Michael Gross reports.
Gross
Michael
M
School of Crystallography, Birkbeck College, University of London, London, UK. www.proseandpassion.com
D000690:Amyotrophic Lateral Sclerosis / Q000628:therapy*; D035843:Biomedical Research / Q000331:legislation & jurisprudence / Q000639:trends*; D019976:Cloning, Organism / Q000331:legislation & jurisprudence* / Q000379:methods; D006801:Humans; D009046:Motor Neurons / Q000166:cytology*; D039901:Totipotent Stem Cells; D006113:United Kingdom; D014480:United Nations